2007 Faculty Publications

Al-Lozi

  1. Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., Neville, H. E., Boylan, K., Mozaffar, T., Belsh, J. M., Ravits, J., Bedlack, R. S., Graves, M. C., McCluskey, L. F., Barohn, R. J., Tandan, R. and Western ALS study group: Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurol. 2007;6:1045-1053.

Baloh

  1. Baloh RH, Schmidt RE, Pestronk A, Milbrandt J. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci 2007 27, 422-430.
  2. Ryu EJ, Wang JY, Le N, Baloh RH, Gustin JA, Schmidt RE, Milbrandt J. Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss. J Neurosci. 2007 Oct 24;27(43):11552-9.
  3. Baloh RH, Salavaggione E, Milbrandt J, Pestronk A. Familial Parkinsonism and Ophthalmoplegia from a Mutation in the Mitochondrial DNA Helicase Twinkle. Arch. Neurol. 2007, 64:998-1000
  4. Baloh RH, Rakowicz W, Gardner R, Pestronk A. Frequent Atrophic Groups with Mixed-type Myofibers is Distinctive to Motor Neuron Syndromes. Muscle and Nerve 2007, 36:107-10

Bateman

  1. Testing a test for Alzheimer disease.
    Bateman RJ, Eidelberg D.
    Neurology. 2007 Feb 13;68(7):482-3. No abstract available.
  2. Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.
    Bateman RJ, Wen G, Morris JC, Holtzman DM.
    Neurology. 2007 Feb 27;68(9):666-9.
  3. Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates.
    Bateman RJ, Munsell LY, Chen X, Holtzman DM, Yarasheski KE.
    J Am Soc Mass Spectrom. 2007 Jun;18(6):997-1006. Epub 2007 Feb 22.

Brody

  1. D. L. Brody and D. M. Holtzman “Active and Passive Immunotherapy for Neurodegenerative Disorders” Annual Review of Neuroscience 31, 175-93, 2008. (PMC2561172)
  2. K. E. Saatman, A.C. Duhaime, R. Bullock, A. Maas, A. Valadka, G. T. Manley, And Workshop Scientific Team and Advisory Panel Members Including: D.L. Brody, C. Contant, P. Dash, R. Diaz-Arrastia, S. Fertig, A.Gean, C. Goodman, W. Gordon, R. Hayes, R. Hicks, J. Langlois, A. Marmarou, D. Moore, G. Murray, D. Okonkwo, L. Papa, L. Phillips, N. Plesnila, C. Robertson, C. Robertson, J. Sahuquillo, R. Silbergleit , E. Steyerberg, N. Stocchett, E. Teasdale, G. Teasdale, N. Temkin, H.Thompson, K. Tong, Li. Wilson, D. Wright. “Classification of Traumatic Brain Injury for Targeted Therapies” J. Neurotrauma 25, 719-38, 2008.
  3. D.L. Brody, S. Magnoni, K.E. Schwetye, M.L. Spinner, T. J. Esparza, N. Stocchetti, G. J. Zipfel, D. M. Holtzman. Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain, Science 321, 1221-1224, 2008 (NIHMSID # 67864)
  4. Mac Donald, C. L., Schwarze N., Vaishnavi, S. N., Epstein, A. A., Synder, A. Z., Raichle, M. E., Shimony, J. S., Brody, D. L. Verbal Memory Deficit Following Traumatic Brain Injury: Assessment using Advanced MRI Methods Neurology 71 1199-1201, 2008. (PMC2575660)

Brunstrom-Hernandez

  1. “Building The Road To Independence” – A Novel Approach to Cerebral Palsy for Parents and Caregivers of Children With Cerebral Palsy, Course Co-Chair. Pediatric Neurology Cerebral Palsy Center and Reaching The Stars, Inc. at St. Louis Children’s Hospital and Washington University
  2. Medical School, St. Louis, MO 2007.Willis AW, Crowner B, Brunstrom JE, Kissel A, Racette BA. High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy. Dev Med Child Neurol 2007 Nov 49(11):818-22.
  3. Crowner B, Brunstrom JE, Racette BA. Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient. (2007) Clin Neuropharmacology. 30(5):310-313.
  4. Fowler EG, Kolobe TH, Damiano DL, Thorpe DE, Morgan DW, Brunstrom JE, Coster WJ, Henderson RC, Pitetti KH, Rimmer JH, Rose J, Stevenson RD; Section on Pediatric Research Committee Task Force. Promotion of physical fitness and prevention of secondary conditions for children with cerebral palsy: Section on Pediatric Research Summit Proceedings. Phys Ther. 2007, Nov; 87 (11): 1495-510.
  5. Sanger TD, et al. Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy. (2007) J Child Neurology. 22(5): 530-7.

Cairns

  1. Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases. Armstrong RA, Lantos PL, Cairns NJ. J Neural Transm. 2007;114(12):1569-77. Epub 2007 Aug 7. PMID: 17680229 [PubMed – indexed for MEDLINE]
  2. A quantitative study of the pathological changes in white matter in multiple system atrophy. Armstrong RA, Cairns NJ, Lantos PL. Neuropathology. 2007 Jun;27(3):221-7. PMID: 17645235 [PubMed – indexed for MEDLINE]
    TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL 3rd, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM, Mackenzie IR.
    Am J Pathol. 2007 Jul;171(1):227-40. PMID: 17591968 [PubMed – indexed for MEDLINE]

Carpenter

  1. Derdeyn CP, Carpenter DA, Videen TO, Grubb RL, Powers WJ. Patterns of infarction in hemodynamic failure. Cerebrovascular Diseases 2007;24:11-19.
  2. Derdeyn CP, Carpenter DA, Videen TO, Grubb RL, Powers WJ. No effect of low-dose statins treatment on cerebral blood flow in humans with atherosclerotic cerebrovascular disease. J Cereb Blood Flow Metab. 2007 Sep;27(9):1643-8. Epub 2007 Mar 14.

Clifford

  1. Azizirad O, Clifford DB, Groger RK, Prelutsky D, Schmidt RE. Histoplasmoma: isolated central nervous system infection with histoplasma capsulatum in a patient with AIDS. Case report and brief review of the literature. Clinical Neurology and Neurosurgery 2007; 109:176-181.
  2. Clifford DB, Mitke MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewede A, Gessesse N, Wolday D, Messele T, Teshome M, and Evans S. Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J NeuroVirol 2007; 13:67-72.
  3. Vidal JE, Clifford D, Ferreira CM, de Oliveira ACP. HIV-associated neuromuscular weakness syndrome in Brazil. Report of the two first cases. Arq Neuropsiquiatr 2007; 65:848-851.
  4. Sacktor N, Nakasujja N, Robertson K, Clifford DB. HIV-associated cognitive impairment in sub-Saharan Africa – the potential effect of clade diversity. Nature Clinical Practice Neurology 2007; 3:436-443.
  5. Lima MA, Marzocchetti A, Autissier P, Tompkins T, Chen Y, Gordon J, Clifford DB, Gandhi RT, Venna N, Berger JR, Koralnik IJ. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. Journal of Virology 2007; 81:3361-3368.
  6. Schifitto G, Zhang J, Evans SR, Sacktor N, Simpson D, Millar LL, Hung VL, Smith E, Miller EN, Ellis RJ, Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D, Clifford DB, The ACTG A5090 Team. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology 2007; 69:1314-1321.
  7. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69:1789-1799.
  8. Evans SR, Yeh T, Sacktor N, Clifford DB, Simpson D, Miller EN, Ellis RJ, Valcour V, Marra CM, Millar L, Schifitto G, for the AIDS Clinical Trials Group and the Neurologic AIDS Research Consortium. Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report for ACTG 5090. HIV Clin Trials 2007; 8:437-446.
  9. Evans SR, Simpson DM, Kitch DW, King A, Clifford DB, Cohen BA, McArthur JC, for the Neurologic AIDS Research Consortium and the AIDS Clinical Trials Group. A randomized trial evaluating Prosaptide® for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. Plos One 2007; 7:e551.

Connolly

  1. Keeling R., Golumbek, P. Streif, Connolly, AM, Effect of weekly prednisone on long term survival and strength in the mdx mouse. Muscle and Nerve.2007 35:43-48.
  2. Hughes MS, Marsh KD, Wallace TA, Connolly AM, Lanza GM, Wickline SA, Sensitive Ultrasonic Detection of Dystrophic Skeletal Muscle in Patients with Duchenne Muscular Dystrophy using an Entropy-Based Signal Reciever, 2007 Ultrasound Med Biol. 2007; 33:1236-43.
  3. Golumbek, P, Keeling, RM, Connolly, AM. Strength and Corticosteroid Responsiveness of Mdx Mice is Unchanged by RAG2 Gene Knockout. Neuromucular Disorders 2007; 17: 276-84.
  4. Wallace, K. Marsh, J, Baldwin, S, Connolly, AM, Keeling, R. Lanz, G. Wickline, S. Hughes, M. Sensitive Ultrasonic Delineation of Steroid Treatment in Living Dystrophic Mice with Energy-based and Entropy-based RadioFrequency Signal Processing. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control;2007; 54:2291-2299.
  5. Golumbek, P, Keeling, RM, Connolly, AM. RAG-2 Gene Knockout in Mice Causes Fatigue. Muscle and Nerve. 2007; 36;471-6.

Corbetta

  1. Shulman, G. L., Astafiev, S. V., McAvoy, M. P., d`Avossa, G., and Corbetta, M. Right TPJ deactivation during visual search: functional significance and support for a filter hypothesis. Cerebral Cortex, (2007) Epub 2007 Jan 31.
  2. He B.J, Snyder A.Z., Vincent J.L., Epstein A., Shulman G.L., Corbetta M. breakdown of functional connectivity in frontoparietal networks underlies behavioral deficits in spatial neglect. Neuron (2007) Mar 15;53(6):905-18.
  3. Sapir A., Kaplan J.B., He B.J., Corbetta M. Anatomical correlates of directional hypokinesia in patients with hemispatial neglect. Journal of Neuroscience (2007) Apr 11;27(15):4045-51
  4. Vincent J.L., Patel G.H., Fox M.D., Snyder A.Z., Baker J.T., Snyder L.H., Corbetta M., Raichle M.E. The intrinsic functional architecture of the primate oculomotor network. Nature (2007) May 3;447(7140):83-6.
  5. Jack A.I., Patel G.H.; Astafiev S.V., Snyder A.Z., Akbudak E., Gordon L. Shulman G.L.,, Corbetta M. Changing Human Visual Field Organization from Early Visual to Extra-Occipital Cortex. PLOS One (2007) May 16;2(5):e452.
  6. Mantini D., Petrucci M.G., Del Gratta C., Romani G.L., Corbetta M. Electrophysiological signatures of resting state networks in the human brain. Proceedings National Academy of Science U S A. 2007 Aug 7;104(32):13170-5. Epub 2007 Aug 1.
  7. He BJ, Shulman GL, Snyder AZ, Corbetta M. The role of impaired neuronal communication in neurological disorders. Current Opinion in Neurology, (2007) 20(6):655-60.
  8. Sylvester C, Shulman G.L., Jack A.I., Corbetta M. Asymmetry of Anticipatory Activity in Visual Cortex Predicts the Locus of Attention and Perception. Journal of Neuroscience (2007) 27(52): 14424-14433.

Cross

  1. Goodman AD, Cohen JA, Cross A, Vollmer T, Rizzo M, Cohen R, Marinucci L, Blight AR: Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study. Multiple Sclerosis 2007; 13:357-368.
  2. Budde MD, Kim JH, Liang H-F, Schmidt RE, Cross AH, Song S-K: Toward Accurate Diagnosis of White Matter Pathology Using Diffusion Tensor Imaging. Mag. Reson. Med. 2007; 57: 688-695
  3. Rinker JR II, Trinkaus K, Nasimth RT, Cross AH: Higher IgG Index found in African-Americans versus caucasians with MS. Neurology 2007; 69:68-72.
  4. Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, Colonna M, Panina-Bordignon P. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2007; 37:1290-1301
  5. Wolinsky JS, Narayana PA, O’Connor P, Coyle PK, Ford C, Johnson K, Miller A, Pardo L, Kadosh S, Ladkani, and the PROMiSe Trial Study Group. Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind placebo-controlled trial. Ann Neurol 2007; 61: 14-24
  6. Sun SW, Liang HF, Schmidt RE, Cross AH, Song SK: Selective vulnerability of cerebral white matter in a mouse model of multiple sclerosis detected using diffusion tensor imaging. Neurobiol Dis 2007; 28:30-38
  7. Budde MD, Kim JH, Liang H-F, Russell JH, Cross AH, Song S-K: Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR in Biomedicine 2007; 20:1-9.
  8. Daginakatte GC, Gadzinski A, Emnett RJ, Stark JL, Gonzales ER, Ping Y, Lee J-M, Cross AH, Gutmann DH: Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proinflammatory cytokines. Exp. Neurol. 2007; 210: 261-267.Lees JR, Cross AH: A little stress is good for you: The conflicting actions of interferon-gamma in demyelination. J. Clin. Invest. 2007; 117: 297-299.
  9. Klawiter EC, Cross AH: B cells: No longer the non-dominant arm of multiple sclerosis. Curr Neurol Neurosci Reports 2007; 7: 231-238.
  10. Naismith RT, Cross AH: Magnetic Resonance Imaging of Multiple Sclerosis. Chapter 5 In: Continuum. Multiple Sclerosis (AH Cross, RT Naismith, Eds). Williams and Wilkins, Hagerstown Maryland, Vol. 13, Issue 5, 2007
  11. Rinker JR II, Cross AH: Diagnosis and Differential diagnosis of multiple sclerosis. Chapter 1 In: Continuum. Multiple Sclerosis (AH Cross, RT Naismith, Eds). Williams and Wilkins, Hagerstown Maryland, Vol. 13, Issue 5, 2007
  12. Benzinger TLS, Cross AH, Xu J, Naismith R, Sun SW, Song SK. Directional diffusivity as a magnetic resonance (MR) biomarker in demyelinating disease. Proc. SPIE, 2007; 6759:1-10 2007

Dhar

  1. Tellez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain 2007; 130: 334-345.

Diringer

  1. Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T, Skolnick BE, Davis SM. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke. 2007 Mar;38(3):1072-5.
  2. Diringer MN, Zazulia AR, Videen TO, Aiyagari A, Powers WJ, Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury J Neurosurg, 2007 Apr;106(4):526-9.
  3. Diringer, M.N., Ferran, J.-M., Broderick, J., Davis, S., Mayer, S.A., Steiner, T., Brun, N.C., Christensen, M.C. Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage, Cerebrovascular Diseases 2007, 24 (2-3), pp. 219-225
  4. Keyrouz SA and Diringer MN; Prevention and Therapy of Vasospasm in Subarachnoid Hemorrhage, Critical Care, 2007;11(4):220.
  5. Mayer, S. A., Davis, S., Steiner, T., Diringer, M. N., and Broderick, J. Factor VIIa for ICH: behind the scenes of an academic-industry collaborative trial Int. J. Stroke, 2007 Aug;2(3):164-8.
  6. Aiyagari V, Diringer MN, Fever control and its impact on outcomes: What is the evidence? Journal of the Neurological Sciences 2007, 261 (1-2), pp. 39-46

Eisenman

  1. Eisenman LN, Shu H-J, Akk G, Wang C, Manion BD, Kress GJ, Evers AS, Steinbach JH, Covey DF, Zorumski CF, Mennerick S, Anticonvulsant and anesthetic effects of a fluorescent neurosteroid analog activated by visible light. Nat Neurosci 2007: 10:523-530

Fagan

  1. Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Wahrle SE, Shah AR, Fagan AM, Smemo S, Kauwe JS, Grupe A, Hinrichs A, Mayo K, Jiang H, Thal LJ, Goate AM, Holtzman DM. Mol Neurodegener. 2007 Apr 12;2:7. PMID: 17430597 [PubMed]
  2. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer’s disease presenilin 1 mutation. Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, Holtzman DM, Morris JC, Goate AM.
    Ann Neurol. 2007 May;61(5):446-53. PMID: 17366635 [PubMed – indexed for MEDLINE]
  3. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Arch Neurol. 2007 Mar;64(3):343-9. Epub 2007 Jan 8. PMID: 17210801 [PubMed – indexed for MEDLINE]

Ford

  1. Ford AL and Lee JM. March 20 Highlight and Commentary: Expanding the therapeutic window for intracerebral hemorrhage. Neurology. 2007 68(12):883.
  2. Ford AL and Zazulia AR. Primary prevention of Ischemic Stroke. European Neurological Disease 2007. London. Touch Briefings. 2007, 24-28.

Fucetola

  1. Hogue, C. W., Freedland, K., Hershey, T., Fucetola, R., Nassief, A., Barzilai, B., Thomas, B., Birge, S., Dixon, D., Schechtman, K. B., and Davila-Roman, V. G. (2007). Neurocognitive outcomes are not improved by 17β-estradiol in post-menopausal women undergoing cardiac surgery. Stroke, 38, 2048-2054.

Galvin

  1. Tarawneh R, Galvin JE. Distinguishing Lewy Body Dementias from Alzheimer disease. Expert Rev Neurotherap, 7:1499-1516, 2007
  2. Galvin JE. Pass the grain; spare the brain. Neurology, 69:1072-1073, 2007.
  3. Galvin JE, Malcom H, Johnson DK, Morris JC. Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease. Neurology 68:1895-1901, 2007.
  4. Galvin JE. Alzheimer Disease: Understanding the Challenges, Improving the Outcome. App Neurol, Suppl (Feb):3-13; 2007.
  5. Galvin JE, Roe CM, Coats MA, Morris JC. Patients rating of cognitive ability: Using the AD8, a brief informant interview as a self rating tool to detect dementia. Arch Neurol 64:725-730, 2007
  6. Galvin JE, Roe CM, Morris JC. Evaluation of cognitive impairment in the older adult: combining brief informant and performance measures. Arch Neurol 64:718-724, 2007
  7. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM-Y, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK. DLB and PDD Working Group Symposium: Boundary Issues and Future Priorities. Neurology 68:812-819, 2007.

Gurnett

  1. Gurnett CA, Dobbs MB, Nordsieck EJ, Keppel C, Goldfarb CA, Morcuende JA, Bowcock AM. Evidence for an additional locus for split hand/foot malformation in chromosome region 8q21.11-q22.3. Amer J Med Genet A 2006; 140:1744-1748.
  2. Gurnett CA, Dobbs MB, Keppel CR, Pincus ER, Jansen, LA, Bowcock AM. Additional evidence of a locus for complex febrile and afebrile seizures on chromosome 12q22-23.3. Neurogenetics 2007; 8:61-63.
  3. Gurnett CA, Bowcock AM, Dietz FR, Morcuende JA, Murray JC, Dobbs MB. Two novel point mutations in the long-range SHH enhancer in three families with triphalangeal thumb and preaxial polydactyly. Am J Med Genet A, 2007; 143:27-32.
  4. Gurnett CA, Keppel C, Bick J, Bowcock AM, Dobbs MB. Absence of HOXD10 mutations in idiopathic clubfoot and sporadic vertical talus. Clin Orthop Relat Res; 2007; Sep;462:27-31.

Hogan

  1. Oliveira GR, Gondim FA, Hogan RE, Rola FH. Heart rate analysis differentiates dialeptic complex partial temporal lobe seizures from auras and non-epileptic seizures. Arquivos de Neuropsiquiatria. 2007;65:565-568.
  2. Oliveira GR, Gondim FA, Hogan RE, Rola FH. Heart rate analysis differentiates dialeptic complex partial temporal lobe seizures from auras and non-epileptic seizures. Arquivos de Neuropsiquiatria. 2007;65:565-568.

Holtzman

  1. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury.
    West T, Atzeva M, Holtzman DM. Dev Neurosci. 2007;29(4-5):363-72. PMID: 17762204 [PubMed – indexed for MEDLINE]
  2. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex.
    Zeng LH, Ouyang Y, Gazit V, Cirrito JR, Jansen LA, Ess KC, Yamada KA, Wozniak DF, Holtzman DM, Gutmann DH, Wong M. Neurobiol Dis. 2007 Nov;28(2):184-96. Epub 2007 Jul 21. PMID: 17714952 [PubMed – indexed for MEDLINE]
    Related Articles Free article in PMC | at journal site
  3. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy.
    Farris W, Schütz SG, Cirrito JR, Shankar GM, Sun X, George A, Leissring MA, Walsh DM, Qiu WQ, Holtzman DM, Selkoe DJ. Am J Pathol. 2007 Jul;171(1):241-51. PMID: 17591969 [PubMed – indexed for MEDLINE]
  4. Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry. Gelfanova V, Higgs RE, Dean RA, Holtzman DM, Farlow MR, Siemers ER, Boodhoo A, Qian YW, He X, Jin Z, Fisher DL, Cox KL, Hale JE.
    Brief Funct Genomic Proteomic. 2007 Jun;6(2):149-58. Epub 2007 Jun 20. PMID: 17584762 [PubMed – indexed for MEDLINE]
  5. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity.
    Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM.
    Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10673-8. Epub 2007 Jun 5. PMID: 17551018 [PubMed – indexed for MEDLINE]
  6. Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury.
    Brody DL, Mac Donald C, Kessens CC, Yuede C, Parsadanian M, Spinner M, Kim E, Schwetye KE, Holtzman DM, Bayly PV.
    J Neurotrauma. 2007 Apr;24(4):657-73. PMID: 17439349 [PubMed – indexed for MEDLINE]
  7. Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Wahrle SE, Shah AR, Fagan AM, Smemo S, Kauwe JS, Grupe A, Hinrichs A, Mayo K, Jiang H, Thal LJ, Goate AM, Holtzman DM. Mol Neurodegener. 2007 Apr 12;2:7. PMID: 17430597 [PubMed]
  8. Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates.
    Bateman RJ, Munsell LY, Chen X, Holtzman DM, Yarasheski KE. J Am Soc Mass Spectrom. 2007 Jun;18(6):997-1006. Epub 2007 Feb 22. PMID: 17383190 [PubMed – indexed for MEDLINE]
  9. Detection of traumatic axonal injury with diffusion tensor imaging in a mouse model of traumatic brain injury.
    Mac Donald CL, Dikranian K, Song SK, Bayly PV, Holtzman DM, Brody DL. Exp Neurol. 2007 May;205(1):116-31. Epub 2007 Feb 12. PMID: 17368446 [PubMed – indexed for MEDLINE]
  10. Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer’s disease presenilin 1 mutation. Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, Holtzman DM, Morris JC, Goate AM.
    Ann Neurol. 2007 May;61(5):446-53. PMID: 17366635 [PubMed – indexed for MEDLINE]
  11. Pittsburgh compound B retention and verification of amyloid deposition. Holtzman DM. Arch Neurol. 2007 Mar;64(3):315-6. No abstract available. PMID: 17353372 [PubMed – indexed for MEDLINE]
  12. Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker. Bateman RJ, Wen G, Morris JC, Holtzman DM. Neurology. 2007 Feb 27;68(9):666-9. PMID: 17325273 [PubMed – indexed for MEDLINE]
  13. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Arch Neurol. 2007 Mar;64(3):343-9. Epub 2007 Jan 8. PMID: 17210801 [PubMed – indexed for MEDLINE]

Hyrc

  1. Rothman SM, Perry G, Yang XF, Hyrc KL, Schmidt BF. Optical Suppression of Seizure-Like Activity with an LED. Epilepsy Res. 2007 74(2-3):201-9.
  2. 18. Hyrc KL, Rzeszotnik Z, Kennedy BR, Goldberg MP, Determining calcium concentration in heterogeneous model systems using multiple indicators. Cell Calcium 2007; 42(6):576-89.

Jacquin

  1. Wang, C.-Z., Shi, M., Yang, L.-L., Yang, R.-Q., Luo, Z.-G., Jacquin, M.F., Chen, Z.-F., and Ding, Y.-Q. Development of the mesencephalic trigeminal nucleus requires a paired homeodomain transcription factor, Drg11.Mol. Cell. Neurosci., 35:368-376, 2007.

Li

  1. Li, M.-J. & Rossi, J. Lentivirus transduction of hematopoietic cells. in Gene transfer: Delivery and expression of DNA and RNA (eds. Friedmann, T. & Rossi, J.) 75-82 (Cold Spring Harbor Labratory Press, Cold Spring Harbor, NY, 2007).
  2. Anderson, J., Li, M.J., Palmer, B., Remling, L., Li, S., Yam, P., Yee, J.K., Rossi, J., Zaia, J. & Akkina, R. Safety and efficacy of a lentiviral vector containing three anti-HIV genes–CCR5 ribozyme, tat-rev siRNA, and TAR decoy–in SCID-hu mouse-derived T cells. Mol Ther 15, 1182-1188 (2007).

Lopate

  1. Bello-Haas VD., Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, Pioro EP, Mitsumoto H. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology 2007;68:2003-7.

Morris

  1. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Walker DG, Caselli R, Kukull W, McKeel D, Morris JC, Hulette C, Schmechel D, Alexander GE, Reiman EM, Rogers J, Stephan DA. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics 2007; 28:311-322.
  2. Roe CM, Xiong C, Miller JP, Morris JC. Education and Alzheimer’s disease without dementia; support for the cognitive reserve hypothesis. Neurology 2007; 68:223-228.
  3. Mukherjee O, Kauwe JSK, Mayo K, Morris JC, Goate AM. Haplotype-based association analysis of the MAPT locus in Late Onset Alzheimer’s disease. BMC Genetics 2007; 8(3).
  4. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 2007; 64.343-349.
  5. Bateman RJ, Wen G, Morris JC, Holtzman DM. Fluctuations of CSF amyloid-β levels; implications for a diagnostic and therapeutic biomarker. Neurology 2007; 68:666-669.
  6. Nowotny P, Simcock X, Bertelsen S, Hinrichs AL, Kauwe JSK, Mayo K, Smemo S, Morris JC, Goate A. Association studies testing for risk for late-onset Alzheimer’s disease with common variants in the β-Amyloid precursor protein (APP). American Journal of Medical Genetics B: Neuropsychiatric Genetics 2007; 144B:469-474.
  7. Behrens MI, Mukherjee O, Tu P-H, Riscic RM, Tenenholz-Grinberg L, Carter D, Paulsmeyer K, Taylor-Reinwald L, Gitcho M, Norton JB, Chakraverty S, Goate AM, Morris JC, Cairns NJ. Neuropathologic heterogeneity in HDDD1, a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. ADAD, 2007; 21:1-7.
  8. Liscic RM, Storandt M, Cairns NJ, Morris JC. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias. Archives of Neurology 2007; 64:535-540.
  9. Bacon D, Fisher RS, Morris JC, Rizzo M, Spanaki MV. American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence. Neurology 2007; 68:1174-1177.
  10. Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, Foong C, White CL, Schneider JA, Kretzschmar HA, Carter D, Taylor-Reinwald L, Paulsmeyer K, Strider J, Gitcho M, Goate AM, Morris JC, Mishra M, Kwong LK, Stieber A, Xu Y, Forman MS, Trojanowski JQ, Lee VM-Y, Mackenzie IRA. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 2007; 171:227-240.
    Galvin JE, Malcom H, Johnson D, Morris JC. Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease. Neurology 2007;68:1895-1901.
  11. Galvin, JE, Roe CM, Coats MA, Morris JC. Patient’s rating of cognitive ability: using the AD8, a brief informant interview as a self rating tool to detect dementia. Arch Neurology 2007; 64:725-730.
  12. Galvin JE, Roe CM, Morris JC. Evaluation of cognitive impairment in older adults: combining brief informant and performance measures. Arch Neurol 2007; 64:718-724.
  13. Kauwe JSK, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, Holtzman DM, Morris JC, Goate AM. Extreme cerebrospinal fluid amyloid β levels identify family with late-onset Alzheimer’s disease Presenilin 1 mutation. Ann Neurol 2007; 61:446-453.
  14. Nowotny P, Bertelsen S, Hinrichs AL, Kauwe JSK, Mayo K, Jacquart S, Morris JC, Goate A. Association studies between common variants in prolyl isomerase Pin1 and the risk for late-onset Alzheimer’s disease. Neuroscience Letters 2007; 419:15-17.
  15. Carpenter BD, Edwards DF, Pickard JG, Palmer JL, Stark S, Neufeld PS, Morrow-Howell N, Perkinson MA, Morris JC. Anticipating relocation: concerns about moving among NORC Residents. J Gerontol Soc Work 2007; 49:165-184.
  16. Morris JC, Landau WM. In Memoriam Leonard Berg, MD (1927-2007). Neurology 2007; 69(12).
  17. Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, Koepsell TD, Morris JC, Kukull WA; the NIA Alzheimer’s Disease Centers. The National Alzheimer’s Coordinating Center (NACC) Database: The Uniform Data Set. ADAD 2007; 21:249-258.
  18. Marcus DS, Wang TH, Parker J, Csernansky JG, Morris JC, Buckner RL. Open access series of imaging studies (OASIS); Cross-sectional MRI data in young, middle aged, nondemented, and demented older adults. J Cog Neurosci 2007; 19:1498-1507.
  19. Wang L, Beg F, Ratnanather T, Ceritoglu C, Younes L, Morris JC, Csernansky JG, Miller MI. Large deformation diffeomorphism and momentum based hippocampal shape discrimination in dementia of the Alzheimer type. IEEE Transactions on Medical Imaging 2007; 26:462-470.
  20. Xiong C, Tang Y, van Belle G, Miller JP, Launer LJ, Bergmann KR, Morris JC. Assessing statistical applications in publications on AD. Neuroepidemiology 2007; 28:235-245.
  21. Xiong C, van Belle G, Miller JP, Yan Y, Gao F, Yu K, Morris JC. A parametric comparison of diagnostic accuracy with three ordinal diagnostic groups. Biometrical journal 2007; 49:682-693.
  22. Edwards DF, Morris JC. Alone and confused: community-residing older African Americans with dementia. Dementia 2007; 6:489-506.
  23. Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, Jehu L, Segurado R, Stone D, Schadt E, Karnoub M, Nowotny P, Tacey K, Catanese J, Sninsky J, Brayne C, Rubinsztein D, Gill M, Lawlor B, Lovestone S, Holmans P, O’Donovan M, Morris JC, Thal L, Goate A, Owen MJ, Williams J. Evidence for novel susceptibility genes for late-onset Alzheimer’s disease from a genome-wide association study of putative functional variants. Human Molecular Genetics 2007; 16:865-873.

Neil

  1. Sizonenko SV, Camm EJ, Garbow JR, Maier S, Inder TE, Williams CE, Neil JJ, Huppi PS, “Developmental Changes and Injury Induced Disruption of the Radial Organization of the Cortex in the Immature Rat Brain Revealed by In Vivo Diffusion Tensor MRI,” Cereb Cortex, 17, 2609-2617 (2007).
  2. Kroenke CD, Van Essen DC, Inder TE, Rees S, Bretthorst GL, Neil JJ, “Microstructural Changes of the Baboon Cerebral Cortex during Gestational Development Reflected in MRI Diffusion Anisotropy,” J Neurosci, 27, 12506-12515 (2007).

Noetzel

  1. King AA, White DA, McKinstry RC, Noetzel M, DeBaun MR. A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes. Neurology 2007;68: 2008-2011.
  2. Ashley WW, Baty JD, Hollander T, Noetzel MJ, Park TS. Long-term motor outcome analysis using a motor score composite following surgical brachial plexus repair. J Neurosurg: Peds 2007; 106:276-281.

Parks

  1. Rauchway AC, Kaiboriboon K, Bansal SK, Kulkantrakorn K, Guo X, Parks BJ, Hayat G. A role for functional classification in the early identification of prognostic factors in ALS. Amyotrophic Lateral Sclerosis. 2007 Aug; 8(4):214-16.

Perlmutter

  1. Earhart GM, Stevens ES, Perlmutter JS, Hong M: Perception of active and passive turning in Parkinson disease. Neurorehab Neural Repair, June 21(2):116-22, 2007 [Epub ahead of print].
  2. Parsian AJ, Racette BA, Zhao JH, Sinha R, Patra B, Perlmutter JS, Parisan A. Association of alpha-synuclein gene haplotypes with Parkinson’s disease. Parkinsonism Relat Disord Feb. 8, 2007 [Epub ahead of print].
  3. Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JAV, Hershey T, Perlmutter JS. Selective defect of in vivo glycolysis in early Huntington disease striatum. Proc Natl Acad Sci 104:2945-2949, 2007. PMC1797149
  4. Hong M, Perlmutter JS, Earhart GM: Enhancement of rigidity in Parkinson disease with activation. Mov Disord 22:1164-1168, 2007.
  5. Powers WJ, Haas RH, Le T, Videen TO, Hershey T, McGee-Minnich L, Perlmutter JS. Normal platelet complex I activity in Huntington’s disease. Neurobiology Disease, 27(1):99-101. 2007. PMC2140002
  6. Tabbal SD, Revilla FJ, Mink JW, Schneider-Gibson P, Wernle AR, de Erausquin GA, Perlmutter JS, Rich KM, Dowling JL. Safety and efficacy of subthalamic nucleus deep brain stimulation performed with limited intraoperative mapping for treatment of Parkinson disease. Neurosurgery 61:119-127, 2007.
  7. Earhart GM, Hong M, Perlmutter JS: Effects of thalamic stimulation frequency on intention and postural tremor. Exp Neurol. 208:257-263,2007. PMC2203380

Piccio

  1. Fenoglio C, Galimberti D, Piccio L, Scalabrini D, Panina P, Buonsanti C, Venturelli C, Lovati C, Forloni G, Mariani C, Bresolin N, Scarpini E. Absence of TREM2 polymorphisms in patients with Alzheimer’s disease and frontotemporal lobar degeneration. Neurosci lett 2007; 411:133-7.
  2. Piccio L, Buonsanti C, Mariani M, Cella M, Gilfillan S, Cross AH, Colonna M, Panina-Bordignon P. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2007; 37:1290-1301.

Racette

  1. Crowner B, Brunstrom J, Racette BA. Pediatric Botulism Due to Therapeutic Botulinum Toxin A Injections. Neuropharmacology 2007;30(5):310-313
  2. Wilk JB, Tobin JE, Suchowersky O, Shill H, Klein C, Wooten GF, Lew M, Mark MH, Guttman M, Watts RL, Singer C, Growdon J, Latourelle JC, Saint-Hilaire M, DeStefano AL, Prakash R, Williamson S, Berg CJ, Sun M, Goldwurm S, Pezzoli G, Racette BA, Perlmutter JS, Parsian A, Baker K, Giroux ML, Litvan I, Pramstaller PP, Nicholson GA, Burn DJ, Chinnery PF, Vieregge P, Slevin JT, Cambi F, MacDonald ME, Gusella JF, Myers RH, Golbe LI. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD Study. Neurology 67(12):2206-10.
  3. Parsian AJ, Racette BA, Zhao JH, Sinha R, Patra B, Perlmutter JS, Parsian A. Association of alpha-synuclein gene haplotypes with Parkinson’s disease.
    Parkinsonism Relat Disord. 2007 13(6):343-7.
  4. Willis AW, Crowner B, Brunstrom JE, Kissel A, Racette BA. High Dose Botulinum Toxin A for the Treatment of Lower Extremity Hypertonicity in Children with Cerebral Palsy. Developmental Med Child Neurology 2007;49:818-822.

Roe

  1. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Medication use as a confounding factor in the use of the cerebrospinal fluid tau/-amyloid42 ratio-reply. Arch Neurol 2007;64:1357-1359.
  2. Khandelwal A, Chandu D, Roe CM, Kopan R, Quatrano RS. Moonlighting activity of presenilin in plants is independent of γ-secretase and evolutionarily conserved. Proceedings of the National Academy of Science USA 2007;104:13337-13342.
  3. Galvin JE, Roe CM, Morris JC. Evaluation of cognitive impairment in the older adult: combining brief informant and performance measures. Archives of Neurology 2007;64:718-724.
  4. Galvin JE, Roe CM, Morris JC. Patient’s rating of cognitive ability: using the AD8, a brief informant interview as a self rating tool to detect dementia. Archives of Neurology 2007;64:725-730.
  5. Roe CM, Xiong C, Miller JP, Morris JC. Education and Alzheimer’s disease without dementia: support for the Cognitive Reserve Hypothesis. Neurology 2007;68:223-228.
  6. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults. Archives of Neurology 2007;64:343-349.

Schlaggar

  1. Schlaggar, B.L. (2007) Are we ready for a Neuropedagogy? Review of “Educating the Human Brain” by M. Posner and M. Rothbart. PsycCritiques, published on-line.
  2. Fair, D.A., Schlaggar, B.L., Cohen, A.L., Miezin, F.M., Dosenbach, N.U.F., Wenger, K.K., Fox, M.D., Snyder, A.Z., Raichle, M.E., Petersen, S.E. (2007) A method for using blocked and event-related fMRI data to study “Resting State” functional connectivity. E-Pub 2007, Jun 18, Neuroimage. 35(1):396-405.
  3. Dosenbach, N.U.F., Fair, D.A., Miezin, F.M., Cohen, A.L., Wenger, K.K., Dosenbach, R.A.T., Fox, M.D., Snyder, A.Z., Vincent, J.L., Raichle, M.E., Schlaggar, B.L., Petersen, S.E. (2007) Distinct brain networks for adaptive and stable task control in humans. Proc Nat Acad Sci. 104(26):11073-11078.
  4. Zeff, B.W., White, B.R., Dehghani, H., Schlaggar, B.L., Culver, J.P. (2007) Retinotopic mapping of adult human visual cortex with high-density diffuse optical tomography. Proc Nat Acad Sci. 104(29):12169-12174.
  5. Schlaggar, B.L., McCandliss, B.D. (2007) Development of neural systems for reading. Annual Reviews of Neuroscience. 30:475-503.
  6. Fair, D.A., Dosenbach, N.U.F., Church, J.A., Cohen, A.L., Miezin, F.M., Barch, D., Petersen, S.E., Schlaggar, B.L. (2007) Development of distinct task control networks through segregation and integration. Proc Nat Acad Sci. 104(33):13507-13512.

Shulman

  1. Sylvester CM, Shulman GL, Jack AI, Corbetta M, Asymmetry of anticipatory activity in visual cortex predicts the locus of attention and perception. Journal of Neuroscience 2007: 27: 14424-14433.
  2. Jack AI, Patel GH, Astafiev SV, Snyder AZ, Akbudak E, Shulman GL, Corbetta M, Changing human visual field organization from early visual to extra-occipital cortex. PloS ONE 2007: 2: e452.
  3. HE BJ, Snyder AZ, Vincent JL, Epstein A, Shulman GL, Corbetta M, Breakdown of functional connectivity in frontoparietal networks underlies behavioral deficits in spatial neglect. Neuron 2007: 53: 905-918.
  4. Shulman GL, Astafiev SV, McAvoy MP, d`Avossa G, Corbetta M, Right TPJ deactivation during visual search: functional significance and support for a filter hypothesis. Cerebral Cortex 2007: 17: 2625-2633.

Van Stavern

  1. Van Stavern RB. Vascular Diseases of the Nervous System. Borsody MK, Ed. In: Comprehensive Board Review in Neurology. 1st ed: New York, Thieme, 2007, pp. 55-79.

Videen

  1. Zazulia AR, Videen TO, Powers WJ: Symptomatic autoregulatory failure in acute ischemic stroke. Neurology 2007; 68:389-390.
  2. Powers WJ, Videen TO, Markham J, McGee-Minnich L, Antenor-Dorsey JV, Hershey T, Perlmutter JS: Selective defect of in vivo glycolysis in early Huntington’s disease striatum. Proc Natl Acad Sci USA 2007; 104:2945-9.
  3. Derdeyn CP, Carpenter DA, Videen TO, Grubb RL Jr, Powers WJ: No effect of low-dose statins treatment on cerebral blood flow in humans with atherosclerotic cerebrovascular disease. J Cereb Blood Flow Metab. 2007;27:1643-8.
  4. Diringer MN, Aiyagari V, Zazulia AR, Videen TO, Powers WJ: Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury. J Neurosurg 2007; 106:526-9.
  5. Derdeyn CP, Carpenter D, Videen TO, Grubb R, Powers WJ: Patterns of infarction in hemodynamic failure. Cerebrovasc Dis. 2007; 24:11-9.
  6. Powers WJ, Haas RH, Le T, Videen TO, Hershey T, McGee-Minnich L, Perlmutter JS; Normal platelet mitochondrial complex I activity in Huntington’s disease. Neurobiol Dis 2007; 27:99-101.

Wong

  1. Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, Griffey MA, Wong M, Sands MS, Cooper JD. Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 2007; 25:150-162. PMID: 17046272
  2. Ouyang Y, Yang XF, Hu XY, Erbayat-Altay E, Zeng LH, Lee JL, Wong M. Hippocampal seizures cause depolymerization of filamentous actin in neurons independent of acute morphological changes. Brain Res 2007; 1143:238-246. PMID: 17320053
  3. Erbayat-Altay E, Zeng LH, Xu L, Gutmann D, Wong M. The natural history and treatment of epilepsy in a murine model of tuberous sclerosis. Epilepsia 2007; 48:1470-1476. PMID: 17484760
  4. Zeng LH, Xu, L, Rensing NR, Sinatra PM, Rothman SM, Wong M. Kainate seizures cause acute dendritic spine loss and actin depolymerization in vivo. J Neurosci 2007; 27:11604-11613. PMID: 17959803
  5. Zeng LH, Ouyang Y, Gazit V, Cirrito JR, Jansen LA, Ess LA, Ess KC, Yamada KA, Wozniak DF, Holtzman DM, Gutmann DH, Wong M. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex. Neurobiol Dis 2007; 28:184-196. PMID: 17714952
  6. Wong M. The utility of tuber-less models of tuberous sclerosis. Epilepsia 2007; 48:1629-1630. PMID: 17692051

Yamada

  1. Xiao, M, Xu, L, Laezza, F, Yamada, K, Feng, S, Ornitz DM: Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14, Molecular and Cellular Neuroscience, 2007, 34: 366-77.
  2. Wozniak, DF, Xiao, M, Xu, L, Yamada, KA, Ornitz, DM: Impaired Spatial Learning and Defective Theta Burst Induced LTP in Mice Lacking Fibroblast Growth Factor 14, Neurobiology of Disease, 2007, 26: 14-26.
  3. Zeng, L-H, Ouyang, Y, Gazit, V, Cirrito, JR, Jansen, LA, Ess, KC, Yamada, KA, Wozniak, DF, Holtzman, DM, Gutmann, DH, Wong, M: Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex, Neurobiology of Disease, 2007, 28: 184-196.

Zazulia

  1. Zazulia AR, Videen TO, Powers WJ. (2007) Symptomatic autoregulatory failure in acute ischemic stroke. Neurology, 68:389-90.
  2. Diringer MN, Aiyagari V, Zazulia AR, Videen TO, Powers WJ. (2007) Hyperoxia does not improve cerebral metabolic rate for oxygen measured by PET in patients with acute severe head injury. J Neurosurgery,106:526-9
  3. Ford AL, Zazulia AR (2007) Primary prevention of ischaemic stroke. European Neurological Disease 2007. London: Touch Briefings, p24-28.

Zempel

  1. Smyth MD, Limbrick DD Jr, Ojemann JG, Zempel J, Robinson S, O’Brien DF, Saneto RP, Goyal M, Appleton RE, Mangano FT, Park TS, Outcome following surgery for temporal lobe epilepsy with hippocampal involvement in preadolescent children: emphasis on mesial temporal sclerosis. J Neurosurg. 2007 Mar;106(3 Suppl):205-10.
  2. Vincent, J, Larson-Prior, L, Zempel. J, Snyder, AZ, Moving GLM ballistocardiogram artifact reduction for EEG acquired simultaneously with fMRI., Clin Neurophysiol. 2007 May;118(5):981-98.
  3. Vincent JL, Patel GH, Fox MD, Snyder AZ, Baker JT, Van Essen DC, Zempel JM, Snyder LH, Corbetta M, Raichle ME., Intrinsic functional architecture in the anaesthetized monkey brain., 2007 Nature. May 3;447(7140):83-6.